| Identification | Back Directory | [Name]
Sch-23390 | [CAS]
87075-17-0 | [Synonyms]
(5R)-8-chloro-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol (+)-7-Chloro-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepin-8-ol (5R)-8-Chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol | [Molecular Formula]
C17H18ClNO | [MOL File]
87075-17-0.mol | [Molecular Weight]
287.78 |
| Hazard Information | Back Directory | [Uses]
SCH-23390 is a dopamine D1-like receptor antagonist (with Ki values of 0.2 nM and 0.3 nM for the D1 and D5 receptor subtypes, respectively). SCH-23390 can shorten the latency period for cocaine-induced lever pressing behavior in rats. SCH-23390 can also eliminate generalized seizures caused by chemical convulsants, such as arecoline (HY-B0726A) and strychnine, and is used in research on neurological disorders related to the dopamine system[1][2]. | [Definition]
ChEBI: (5R)-8-chloro-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol is a benzazepine. | [References]
[1] Dakota B Zinani, et al. SCH23390 and a humanized anti-cocaine mAb decrease the latency to cocaine-induced reinstatement of lever pressing behavior in rats that self-administer cocaine. Sci Rep. 2023 Sep 4;13(1):14566. DOI:10.1038/s41598-023-41284-1 [2] J A Bourne, et al. SCH 23390: the first selective dopamine D1-like receptor antagonist. DOI:10.1111/j.1527-3458.2001.tb00207.x |
|
| Company Name: |
TargetMol
|
| Telephone: |
400-821-0310 15002144251 |
| Website: |
www.targetmol.cn/ |
|